Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by CancerVAX, Inc
CancerVax Passes First Test with Flying Colors
December 20, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Targets Hard to Treat Pancreatic Cancer
December 11, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Lands Top Cancer Expert
November 19, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Taps Flashpoint Therapeutics’ Nanotechnology Platform to Drive Universal Cancer Treatment
August 29, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Files New Patent for Its Novel Universal Cancer Treatment Platform
August 27, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Adds Key Members to Its Research Team
August 01, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Successfully Uses Nobel Prize Chemistry to Achieve Universal Cancer Vaccine Targeting Milestone
May 21, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Announces Promising New Drug to Treat a Deadly Children’s Cancer
April 16, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Launches $5 Million Funding Round
April 03, 2024
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX CEO Ryan Davies Discusses the Company’s Growing Pipeline of Cancer Treatments
September 14, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX Expands Development Pipeline to Include a Universal CAR-T Cell Platform
September 12, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX CEO Ryan Davies Discusses Cancer Drug Development with Dr. Ezra Cohen
November 02, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX CEO Ryan Davies Discussed Cancer Immunotherapy with UCLA Physician-Scientist
August 24, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
World Renowned Biomedical Professor Jonathan Lakey Joins CancerVAX Board of Advisors
July 26, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX CEO Ryan Davies Discusses Biotech Entrepreneurship with Pyxis Oncology CEO Dr. Lara Sullivan
July 10, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX Reports Significant Progress on Universal Cancer Vaccine Development at UCLA
June 27, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
Biotech Executive Michael Smith Discusses the FDA Drug Development Process with CancerVAX CEO Ryan Davies
June 16, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX Launches $10 Million Funding Round
June 14, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX Reports Positive Progress on Kids Cancer Immunotherapy Treatment
June 12, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX CEO Ryan Davies and Raymond Vennare Discuss the Cancer Fighting Role of Universities
June 06, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
Biotech Entrepreneur and Venture Capitalist Dinesh Patel Discusses Therapeutics and Medical Devices with CancerVAX CEO Ryan Davies
May 17, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
Former Pfizer Legal Counsel Discusses Gene Therapy with CancerVAX CEO Ryan Davies
April 20, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX CEO Ryan Davies Discusses Cancer Research with Leading Pediatric Hematologic Oncologist
April 12, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX Lands Byron Elton
April 03, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax CEO Ryan Davies Speaks with University of Utah Chemistry Professor about the Future of Therapeutic Research
March 24, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
Leading Diabetes Researcher Speaks on his Groundbreaking ‘Edmonton Protocol’ with CancerVAX CEO Ryan Davies
March 22, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVAX CEO Ryan Davies Sits Down with Oncology Research Leader
March 20, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Universal Cancer Vaccine Being Developed by UCLA
March 17, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
CancerVax Files Non-Provisional Patent for Universal Cancer Vaccine
March 16, 2023
From
CancerVAX, Inc
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.